Monoclonal antibodies in the treatment of AL amyloidosis: co‐targetting the plasma cell clone and amyloid deposits
Author:
Affiliation:
1. Department of Haematooncology University Hospital Ostrava and Faculty of Medicine Ostrava Czech Republic
2. Faculty of Medicine University of Ostrava Ostrava Czech Republic
3. Faculty of Science University of Ostrava Ostrava Czech Republic
Funder
Ministry of Health
European Regional Development Fund
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16436
Reference72 articles.
1. Daratumumab-based therapy in patients with heavily-pretreated AL amyloidosis
2. Improvement in Global Longitudinal Strain (GLS) Correlates with NT-Probnp Response in Patients with Cardiac Amyloidosis Treated on a Phase 1b Study of Anti-Amyloid Mab Cael-101
3. Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone
4. Translocation t(11;14) Is Associated With Adverse Outcome in Patients With Newly Diagnosed AL Amyloidosis When Treated With Bortezomib-Based Regimens
5. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current status and prospect of anti-amyloid fibril therapy in AL amyloidosis;Blood Reviews;2024-07
2. The mechanism of action, pharmacological characteristics, and clinical utility of the amyloid depleter birtamimab for the potential treatment of AL amyloidosis;Leukemia & Lymphoma;2024-04-11
3. Association Between Hematologic Response and Change in Health-Related Quality of Life Among Patients with Light-Chain (AL) Amyloidosis;Patient Related Outcome Measures;2023-10
4. Cardiovascular toxicity from therapies for light chain amyloidosis;Frontiers in Cardiovascular Medicine;2023-07-05
5. Cardiac amyloidosis presenting as pulmonary arterial hypertension: A case report;World Journal of Clinical Cases;2023-04-26
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3